Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Primer on Copay Accumulator Programs

Donald Miller, PharmD, & Laura Sampson, PA-C  |  Issue: August 2022  |  June 17, 2022

 

GLOSSARY

Coinsurance – The percentage of costs of a covered healthcare service paid by a patient (e.g., 20% coinsurance) after they have paid their deductible.

Copay – A flat fee paid by a patient to access healthcare services.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Copay accumulator adjustment program (CAAP) – A program within an insurance plan whereby a manufacturer’s copay assistance program payments do not count toward the patient’s deductible and out-of-pocket maximum. The manufacturer copay assistance pays for prescriptions until the maximum value is reached; only then do the patient’s costs begin counting toward their annual deductible and out-of-pocket maximum.

Cost sharing – The share of costs covered by insurance that a patient pays out of their own pocket. This term generally includes deductibles, coinsurance and copays or similar charges.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Deductible – The amount a patient needs to pay before health insurance will cover services.

Out-of-pocket costs – Expenses for medical care that are not reimbursed by insurance, including deductibles, coinsurance and copays for covered services, as well as all costs for services that aren’t covered.

Out-of-pocket maximum – The total maximum amount a patient may have to pay during any given plan year.


Donald Miller, PharmD, is professor of pharmacy practice, North Dakota State University, Fargo.

Laura Sampson, PA-C, practices at Arnold Arthritis & Rheumatology in Skokie, Ill.

Page: 1 2 3 | Single Page
Share: 

Filed under:Interprofessional PerspectiveLegislation & Advocacy Tagged with:Access to careAdvocacy Leadership Conferencecopay accumulatorsdrug costsLegislation & Advocacy

Related Articles
    felipe caparros / shutterstock.com

    Copay Accumulator Programs Can Derail Rheumatologic Treatment Plans

    February 13, 2020

    As the medications for rheumatology become more expensive, the need for patient financial assistance becomes paramount. Unfortunately, commercially insured patients are finding it difficult to afford the exorbitant copays required by their plans, and the latest strategy of pharmacy benefit managers (PBMs) threatens to derail rheumatologic treatment goals. High deductible plans combined with copay accumulator…

    Copay Accumulator & Maximizer Programs Threaten Access to Treatment

    July 6, 2023

    As health insurance companies and third-party benefit managers continue to use copay accumulators and maximizers to shift the cost of specialty drugs to patients, the ACR continues to advocate against programs that limit copay assistance.

    Rheumatologists Concerned High Healthcare Costs May Encourage Patients to Forgo, Delay Treatment

    June 14, 2017

    While members of Congress debate healthcare legislation, rheumatologists say many of their patients struggle to afford everything from generic drugs to insurance copayments for physical therapy. “It’s a mess. The cost of prescriptions and the rationale for those rising costs in the U.S. right now—it’s just a mess,” says James R. O’Dell, MD, Stokes-Shackleford Professor of…

    ACR Leads Resolution to Address Copay Accumulator Policies at AMA House of Delegates Meeting

    November 6, 2020

    If passed, the ACR-authored resolution will direct the AMA to advocate for copay accumulator bans at state and federal levels. Several other specialties and state medical associations have joined the resolution as cosponsors.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences